Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
On 13 Aug, 2021 By admin 0 Comments
August, 2021
Highlights
- Infection-enhancing antibodies have been detected in symptomatic Covid-19
- Antibody dependent enhancement (ADE) is a potential concern for vaccines
- Enhancing antibodies recognize both the Wuhan strain and Delta variants
- ADE of Delta variants is a potential risk for current vaccines
- Vaccine formulations lacking ADE epitope are suggested
Abstract